Revenue for the quarter was $808,000 with operating income of $8.93 million.
The Newyork, New York (NY)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $20.66 million.
This is a developing story. Click
here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts
here.